Body image concerns drive interest in GLP-1 weight loss drugs, study finds
L-carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality
In 2024 the Food and Drug Administration added cardiovascular risk as a reason to be prescribed the GLP-1 drug Wegovy, grounded in results from a major trial that showed fewer heart attacks, strokes, and cardiovascular deaths in adults with obesity or overweight and established heart disease
In both mice and humans, two homologs have been identified: CHAC1 and CHAC2
Most standard functions, including detoxification of undesirable substances and cellular protection against oxidative damage, are carried out with the help of glutathione
In contrast, Mazdutide remains limited to clinical trials, making it unavailable for general use